ECSP055953A - Granisetron transdermico - Google Patents

Granisetron transdermico

Info

Publication number
ECSP055953A
ECSP055953A EC2005005953A ECSP055953A ECSP055953A EC SP055953 A ECSP055953 A EC SP055953A EC 2005005953 A EC2005005953 A EC 2005005953A EC SP055953 A ECSP055953 A EC SP055953A EC SP055953 A ECSP055953 A EC SP055953A
Authority
EC
Ecuador
Prior art keywords
granisetron
transderman
skin
flow
substantially increase
Prior art date
Application number
EC2005005953A
Other languages
English (en)
Inventor
Adam Charles Watkinson
Original Assignee
Strakan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9952502&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP055953(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Strakan Ltd filed Critical Strakan Ltd
Publication of ECSP055953A publication Critical patent/ECSP055953A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Parches adhesivos para la administración transdérmica de granisetrón, comprenden un adhesivo acrílico conteniendo porciones nucleofílicas no ácidas que incrementan substancialmente el flujo de granisetrón a través de la piel.
EC2005005953A 2003-02-05 2005-08-05 Granisetron transdermico ECSP055953A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0302662.2A GB0302662D0 (en) 2003-02-05 2003-02-05 Transdermal granisetron

Publications (1)

Publication Number Publication Date
ECSP055953A true ECSP055953A (es) 2006-01-16

Family

ID=9952502

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005953A ECSP055953A (es) 2003-02-05 2005-08-05 Granisetron transdermico

Country Status (33)

Country Link
US (3) US7608282B2 (es)
EP (1) EP1589956B1 (es)
JP (2) JP4146486B2 (es)
KR (1) KR100893158B1 (es)
CN (3) CN102526043A (es)
AT (1) ATE368454T1 (es)
AU (1) AU2004210181B2 (es)
BR (1) BRPI0407280A (es)
CA (1) CA2515094C (es)
CR (1) CR7923A (es)
CY (1) CY1106811T1 (es)
DE (1) DE602004007888T2 (es)
DK (1) DK1589956T3 (es)
EC (1) ECSP055953A (es)
ES (1) ES2287695T3 (es)
GB (1) GB0302662D0 (es)
GE (1) GEP20084390B (es)
HK (1) HK1082199A1 (es)
HR (1) HRP20050695B1 (es)
IL (1) IL169881A (es)
IS (1) IS7997A (es)
MA (1) MA27616A1 (es)
MX (1) MXPA05008343A (es)
NO (1) NO331441B1 (es)
NZ (1) NZ541103A (es)
PL (1) PL218351B1 (es)
PT (1) PT1589956E (es)
RS (1) RS51696B (es)
RU (1) RU2355387C2 (es)
SI (1) SI1589956T1 (es)
UA (1) UA83362C2 (es)
WO (1) WO2004069141A2 (es)
ZA (1) ZA200506128B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
WO2006028863A1 (en) * 2004-09-01 2006-03-16 Nexmed Holdings, Inc. Transdermal antiemesis delivery system, method and composition therefor
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
NZ563946A (en) 2005-06-03 2012-02-24 Acrux Dds Pty Ltd Testosterone containing non-occlusive transdermal drug delivery composition for application to the arm pit / axilla
CN100464752C (zh) * 2005-11-01 2009-03-04 中国人民解放军第二军医大学 格拉司琼巴布剂及其制法
EP1842541A1 (en) * 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Plant components and extracts and uses thereof
WO2008115599A1 (en) * 2007-03-21 2008-09-25 Alza Corporation Apparatus and method for transdermal delivery of a 5-hydroxytrytamine antagonist
US20080242696A1 (en) * 2007-03-27 2008-10-02 Chemagis Ltd. Crystalline granisetron base and production process therefor
JP2008297277A (ja) * 2007-06-01 2008-12-11 Taiyo Yakuhin Kogyo Kk 注射剤の安定化法
KR100929560B1 (ko) 2008-01-09 2009-12-03 에코 퍼시픽 엘티디 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제
CN101721394B (zh) * 2008-10-29 2013-04-17 大连理工大学 一种格拉司琼和/或其盐酸盐贴剂
TW201021856A (en) 2008-12-01 2010-06-16 Genovate Biotechnology Co Ltd Antiemetic patch
CN101716163B (zh) * 2009-12-24 2013-07-31 沈阳药科大学 一种来曲唑靶向定位缓释透皮贴剂及其制备方法
CN101836949A (zh) * 2010-02-11 2010-09-22 上海现代药物制剂工程研究中心有限公司 含有止吐活性药物的透皮凝胶制剂及制备方法
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders
CN102293761B (zh) * 2010-06-22 2014-01-08 浙江省医学科学院 含止吐剂成份的透皮吸收贴剂
CN102462672B (zh) * 2010-11-17 2013-12-04 汪晴 一种雷莫司琼透皮贴剂及其制备方法
CN102178660B (zh) * 2011-04-19 2012-08-08 上海现代药物制剂工程研究中心有限公司 微孔型盐酸格拉司琼透皮贴膜及其制法
JP5981431B2 (ja) 2011-07-07 2016-08-31 帝國製薬株式会社 セロトニン受容体拮抗薬含有貼付剤
CN102908345A (zh) * 2011-08-01 2013-02-06 河南康倍得药业有限公司北京技术开发中心 适于透皮给药的含格拉司琼的药物组合物及其制备与应用
JPWO2014051055A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 キヌクリジンウレア誘導体及びその医薬用途
RU2667621C2 (ru) * 2014-04-30 2018-09-21 Кимберли-Кларк Ворлдвайд, Инк. Устройства и способы трансдермальной доставки лекарств
CN105520921B (zh) * 2015-01-09 2018-12-25 中国科学院理化技术研究所 一种含有格拉司琼的长效透皮贴剂
CN110087640A (zh) 2016-12-20 2019-08-02 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
KR102614709B1 (ko) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 아세나핀 및 폴리실록산 또는 폴리이소부틸렌을 함유하는 경피흡수 치료 시스템
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템
WO2020118091A1 (en) 2018-12-05 2020-06-11 Starton Therapeutics, Inc. Ondansetron in-adhesive transdermal patch
KR102537845B1 (ko) 2020-02-19 2023-05-30 신신제약 주식회사 그라니세트론을 함유하는 경피흡수제제

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3269994A (en) * 1963-09-30 1966-08-30 Catalin Corp Of America Solvent-resistant pressure-sensitive adhesive coating and method of producing the same
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
JP2001513124A (ja) * 1997-02-21 2001-08-28 アドヒーシブズ リサーチ，インコーポレイテッド 感圧接着性薬剤透皮投与複合材とそれに使用する感圧接着性薬剤
AU3170697A (en) * 1997-05-30 1998-12-30 Minnesota Mining And Manufacturing Company Transdermal drug delivery device for the delivery of tropisetron or granisetron
US6312715B1 (en) * 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
US6136807A (en) 1998-11-10 2000-10-24 3M Innovative Properties Company Composition for the transdermal delivery of lerisetron
ES2261178T3 (es) * 1999-02-09 2006-11-16 Samyang Corporation Una composicion transdermal de un agente anti-vomito y una preparacion de la misma.
EP1044684B1 (en) * 1999-04-13 2004-07-28 Nitto Denko Corporation Percutaneously absorbable preparation
JP4378028B2 (ja) * 1999-04-13 2009-12-02 日東電工株式会社 経皮吸収型製剤
AU5325000A (en) * 1999-06-05 2000-12-28 David Houze Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
DE19929197A1 (de) * 1999-06-25 2000-12-28 Novosis Pharma Ag Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung
DE10015783C2 (de) 2000-03-30 2003-12-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
US20020172712A1 (en) 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
GB0119012D0 (en) * 2001-08-03 2001-09-26 Strakan Group Plc Transdermal delivery of drugs
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron

Also Published As

Publication number Publication date
JP2006516601A (ja) 2006-07-06
BRPI0407280A (pt) 2006-01-31
DK1589956T3 (da) 2007-10-01
KR100893158B1 (ko) 2009-04-16
HRP20050695B1 (hr) 2013-11-08
AU2004210181A1 (en) 2004-08-19
US20060177493A1 (en) 2006-08-10
ES2287695T3 (es) 2007-12-16
WO2004069141A2 (en) 2004-08-19
IS7997A (is) 2005-08-24
EP1589956A2 (en) 2005-11-02
KR20050116365A (ko) 2005-12-12
WO2004069141A3 (en) 2004-10-07
NO331441B1 (no) 2012-01-02
CR7923A (es) 2008-10-29
CY1106811T1 (el) 2012-05-23
UA83362C2 (uk) 2008-07-10
RU2005127599A (ru) 2006-01-20
CN102416009B (zh) 2013-09-11
CA2515094A1 (en) 2004-08-19
AU2004210181B2 (en) 2009-11-19
US7608282B2 (en) 2009-10-27
CN102526043A (zh) 2012-07-04
HRP20050695A2 (en) 2006-02-28
MA27616A1 (fr) 2005-11-01
NO20053663L (no) 2005-11-04
US20120258164A1 (en) 2012-10-11
US20100008974A1 (en) 2010-01-14
EP1589956B1 (en) 2007-08-01
DE602004007888D1 (en) 2007-09-13
NZ541103A (en) 2007-01-26
CN102416009A (zh) 2012-04-18
IL169881A0 (en) 2007-07-04
NO20053663D0 (no) 2005-07-28
PL218351B1 (pl) 2014-11-28
PT1589956E (pt) 2007-08-23
DE602004007888T2 (de) 2008-04-17
CN1747724A (zh) 2006-03-15
GEP20084390B (en) 2008-06-10
JP4146486B2 (ja) 2008-09-10
GB0302662D0 (en) 2003-03-12
IL169881A (en) 2011-12-29
RS51696B (en) 2011-10-31
MXPA05008343A (es) 2006-01-31
RU2355387C2 (ru) 2009-05-20
CA2515094C (en) 2008-12-09
SI1589956T1 (sl) 2007-10-31
RS20050600A (en) 2007-12-31
AU2004210181A2 (en) 2004-08-19
JP2008195738A (ja) 2008-08-28
ZA200506128B (en) 2006-12-27
HK1082199A1 (en) 2006-06-02
ATE368454T1 (de) 2007-08-15
WO2004069141B1 (en) 2004-12-23
PL379027A1 (pl) 2006-06-26

Similar Documents

Publication Publication Date Title
ECSP055953A (es) Granisetron transdermico
MY151020A (en) Transdermal therapeutic system
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
CY1105877T1 (el) Οφθαλμικες συνθεσεις πepιεχουσες συνepγιστικο συνδυασμο τριων πολυμepων
CR8858A (es) Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados
MX2007015424A (es) Formulaciones ungueales topicas.
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
ATE524167T1 (de) Transdermales pflaster
GT200500268A (es) Inhibidores de la adenilato ciclasa soluble
CR10038A (es) Analogo de la diazonamida a
CR6707S (es) Banda de rodadura
CR7141A (es) Liso ao estremo
GT200500165A (es) Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
CY1114057T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης
ITMI20030559A1 (it) Sottopiede adesivo protettivo cutaneo.
ES1058540Y (es) Dispositivo para la fijacion de sombrillas.
CR7484A (es) Triazolopirimidas funguicidas, procedimientos para su obtencion y el uso de las mismas para combatir hongos nocivos, asi como productos que las contienen
HN1999000192A (es) Antagonistas de 54t1 para terapia antidepresiva